On the same day the Illinois Department of Financial and Professional Regulation announced more than 37 million total April sales for adult use of cannabis, the Illinois Department of Public Health announced that sales of medical cannabis for April reached $31,111,926.69.
For 2020, retail sales by licensed medical cannabis dispensaries has totaled $109,278,769.20.
Since November 2015, licensed medical cannabis dispensaries have sold a total of $620,577,371.67.
The total April medical and adult use sales equaled $68,372,424.40.
Retail sales of medical cannabis for April included $14,481,643.61 in dry flower and $16,630,283.08 in concentrates/infused-products.
Licensed medical cannabis dispensaries served 56,541 unique patients, who purchased 978,196 grams of dry cannabis.
The IDPH also announced approval for 113,458 qualifying patients’ applications (including 644 persons under 18 years of age), since it began accepting applications for the Medical Cannabis Registry Program on September 2, 2014.
Illinois has a total of 55 licensed medical cannabis dispensaries.
For 2020, wholesale sales by cultivation centers equaled $94,330,470.19.
Wholesale sales since November 2015 by cultivation centers has totaled $396,594,921.62.
All sales figures reflect voided sales. Prior to 2017, voided sales were not reflected in these figures.
Since the stay-at-home order, dispensaries are permitted to sell medical cannabis outside of their limited access area on their property or on a public walkway or curb adjacent to the dispensary.
Medical cannabis patients will be able to continue to utilize their designated caregiver to purchase medicine for them. However, dispensaries may not deliver medical cannabis to a patient or caregiver’s home.
These rules do not apply to adult-use cannabis sales; those must still take place inside the limited access area. A complete list of the rules extended may be found here.
In similar news, the IDPH also announced the Opioid Alternative Pilot Program now has 1,320 registered patients and 1,379 patients awaiting physician certification.
The IDPH launched the Opioid Alternative Pilot Program January 31, 2019.
The OAPP provides access to medical cannabis for individuals who have or could receive a prescription for opioids as certified by a physician licensed in Illinois.